Global Pharmatech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBLP research report →
Price Chart
About the company
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA.
- CEO
- Mei Sheng Liao
- IPO
- 2002
- Employees
- 217
- HQ
- Hong Kong, MA, HK
Get TickerSpark's AI analysis on GBLP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $33.25M
- P/E
- 800.90
- PEG
- 16.02
- P/S
- 63.82
- P/B
- -3671.26
- EV/EBITDA
- 702.07
- Div Yield
- 0.00%
- Gross Margin
- 26.84%
- Op Margin
- 6.37%
- Net Margin
- 8.25%
- ROE
- -82.77%
- ROIC
- 40.68%
Latest fiscal year · YoY change
- Revenue
- $310.89K+368.4%
- Gross Profit
- $34.66K-20.9%
- Op Income
- $-67,815
- Net Income
- $-67,728+51.1%
- EPS
- $-0.00+50.0%
- OCF Growth
- +107.5%
- FCF Growth
- +0.0%
- 52W High
- $0.11
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.05
- Beta
- 0.28
- RSI (14)
- 61
- Avg Volume
- 526
No earnings-call transcripts are available for GBLP yet.
- Free Float
- 16.3%
- Shares Outstanding
- 415.21M
- Float Shares
- 67.71M
Our GBLP coverage
Recent articles, reports, and earnings notes.
No research on GBLP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GBLP report →